Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

12:45 PM - 2:00 PM PT

Radiation and Cancer Physics 6: Innovations in Planning Algorithm and Quality Assessment
Speaker: Ger, Rachel, PhD - Johns Hopkins School of Medicine, Baltimore, MD
12:50 PM - 12:55 PM PT

1054 - Development and Prospective Validation of a Fully AI-Driven Online Adaptive Radiotherapy Workflow
Speaker: Zhou, Guan-Qun, MD, PhD - Sun Yat-Sen University Cancer Center, Guang Dong Province, Guangdong
12:55 PM - 1:00 PM PT

1055 - Implementation of Knowledge-Based Planning As a Quality Assurance Feedback Tool for a Multicentre Prostate Clinical Trial (TROG 18.01 NINJA)
Speaker: Martin, Jarad, MD, MB, ChB, PhD, BSc FRANZCR GAustMS - Calvary Mater Newcastle Hospital, Newcastle, NSW
12:55 PM - 1:05 PM PT

301 - Dose Escalated vs. Standard Dose Post Operative Radiation Therapy for High Risk Meningiomas: An International Individual Patient Level Meta-Analysis (FIRESTORM)
Speaker: Singh, Raj, MD - The Ohio State University Wexner Medical Center, Columbus, OH
12:55 PM - 1:05 PM PT

307 - Phase IB/II Study of Trifluridine/Tipiracil Hydrochloride (FTD/TPI) Plus Radiation Therapy for the Treatment of the Liver in Patients with Hepatic Metastases from Colorectal and Pancreatic Cancer
Speaker: Wo, Jennifer, MD - Massachusetts General Hospital/ Harvard Medical School, Boston, MA
12:55 PM - 1:05 PM PT

313 - Re-Examining Post-Operative Chemoradiotherapy in Head and Neck Cancer: An Updated Long-Term Combined Analysis of RTOG 9501/EORTC 22931
Speaker: Zumsteg, Zachary, MD - Cedars-Sinai Medical Center, Los Angeles, CA
12:55 PM - 1:05 PM PT

318 - Radiation Activates the AIM2 Inflammasome to Enhance Immunotherapy by Triggering IL-1ß Signaling and DC Activation in Colorectal Cancer
Speaker: Xia, Fan, MD, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
12:55 PM - 1:05 PM PT

323 - Quantifying Treatment Plan Quality in Non-Small Cell Lung Cancer Radiotherapy Based on Pairwise Preferences
Speaker: Zhang, Jiahan, PhD - Icahn School of Medicine at Mount Sinai, New York, NY
1:00 PM - 1:05 PM PT

1056 - Vision-Language AI Model for Detecting PET/CT-Occult Lymph Node Metastasis in Early-Stage NSCLC Treated with SABR to Prevent Regional Recurrence
Speaker: Xu, Hui, PhD - MD Anderson Cancer Center, Houston, TX
1:05 PM - 1:10 PM PT

1057 - AI Automated Measures of Tumor Burden and Correlation with Pre-Treatment Circulating Tumor DNA in Head and Neck Cancer
Speaker: Bakhtiar, Mina, MD - Mass General Brigham/Massachusetts General Hospital/Harvard Med School, Boston, MA
1:05 PM - 1:15 PM PT

302 - Elective Target Stereotactic Spine Radiosurgery (SSRS) Reduces Risk of Long-Term Treatment Failure Compared to Involved Target SSRS: Final Analysis of A Prospective Randomized Phase II Trial
Speaker: Hsu, Feng-Ming, MD, PhD - National Taiwan University Cancer Center, Taipei, Taipei
1:05 PM - 1:15 PM PT

308 - Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-Line Immunotherapy: A Phase II Clinical Study
Speaker: Hsu, Shu Jung, MD, PhD - Zhongshan Hospital Fudan University, Shanghai, Shanghai